Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Structural heart disease

Post TAVR Dialysis: a Severe Complication Less and Less Frequent

The prevalence of pre-procedural kidney failure in patients undergoing transcatheter aortic valve replacement (TAVR) can be as high as...
solaci -
Learn More
Structural heart disease

Bleeding and Mortality in Transcatheter Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) is much less invasive than surgical replacement. This is associated with a substantial...
solaci -
Learn More
Structural heart disease

How to standardize frailty in aortic stenosis patients

Frailty is the patient’s diminished capacity to recover after pathological or iatrogenic processes. It has a fundamental...
solaci -
Learn More
Coronary disease

Incomplete Revascularization Is Associated with Mortality in TAVR

Courtesy of Dr. Carlos Fava. TAVR has proven to be beneficial for inoperable and high-risk patients, as well as...
solaci -
Learn More
Structural heart disease

Valve Deterioration after TAVI Is Rare and Should Not Prevent Advancement to Younger Populations

Durability ─or better yet, lack of deterioration─ is still a matter of debate when considering transcatheter aortic...
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | When is the optimal timing for PCI: before or during TAVI

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Conrad...
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | TAVI intermediate risk: Reality or passion?

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Flavio...
solaci -
Learn More
Structural heart disease

SOLACI CACI 2017 | Prevention of valvular thrombosis: antiaggregation or anticoagulation?

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr....
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

AHA 2024 | VANISH2 Trial

Dr. Omar Tupayachi - 0
Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

Dr. Omar Tupayachi - 0
It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Dr. Omar Tupayachi - 0
Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Institutional News

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy